CHAPEL HILL, N.C., Nov. 3, 2017 /PRNewswire/ -- Medical education programs in the pharmaceutical industry are evolving tomeet new transparency requirements as well as interest in outcomes-focused information.
A recent study by research and consulting leader Best Practices, LLC found that a majority of companies in the study are using multi-disciplinary programs
At the same time, new compliance and transparency rules have tempered the sponsorship of medical education programs by the pharmaceutical industry. The study investigates emerging medical education trends at pharmaceutical organizations regarding program mix, value and technology. The study also informs medical affairs and medical education function leaders on measuring effectiveness and future directions for this group.
Best Practices in Leading Medical Education Program Strategy: Establishing the Right Structures, Resources and Activities to Optimize Biopharmaceutical Education Groups, is a 58-page benchmarking report that examines the different factors that affect the effectiveness of medical education groups.
Medical Affairs executives, directors and managers who want to understand the most important current trends and future direction of medical education programs during this transitional period will profit from the leading practices, managerial insights and benchmark metrics contained in this report.
The insights and benchmark metrics contained in this report are drawn from interviews and benchmarking surveys with 23 leaders from 19 top biopharmaceutical and medical device companies. More than 65 percent of the participants are at the level of director.
This report features original research and yields rich data on the following topic areas:
To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1471.htm.
For related research, visit the Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLCBest Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.
View original content:http://www.prnewswire.com/news-releases/emerging-trends-in-medical-education-in-the-pharmaceutical-industry-is-the-focus-of-best-practices-llc-study-300549496.html
SOURCE Best Practices, LLC
Subscribe to our Free Newsletters!
Exfoliative dermatitis or erythroderma is a skin condition where the skin becomes reddened and ...
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...View All